Creating a patient and community advisory committee at the Canadian Agency for Drugs and Technologies in Health.

Int J Technol Assess Health Care

Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Ave, Ottawa, Ontario, CanadaK1S 5S8.

Published: January 2021

In recognition of patients' roles using, and contributing to, a publicly funded health system, the Canadian Agency for Drugs and Technologies in Health (CADTH) created a Patient and Community Advisory Committee. Twelve members bring lived experiences of chronic illness, progressive illness, mental illness, trauma, traveling long distances for treatment, and caregiving to an ill child, parent, or spouse. Members contribute their own insights and ideas but do not represent specific organizations or viewpoints. This paper explores how CADTH determined the committee's role, whether to have individuals or organizations as members, and how to recruit for diversity. The creation of this committee is changing how CADTH engages with patients.

Download full-text PDF

Source
http://dx.doi.org/10.1017/S0266462320002251DOI Listing

Publication Analysis

Top Keywords

patient community
8
community advisory
8
advisory committee
8
canadian agency
8
agency drugs
8
drugs technologies
8
technologies health
8
creating patient
4
committee canadian
4
health recognition
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!